← FDA DRUG APPROVALS
FDA ANDA · ANDA210319
MEMANTINE HYDROCHLORIDE
memantine hydrochloride oral
Sponsor: MEDLEY PHARMS
APPLICATION
ANDA210319
TYPE
ANDA
ORIGINAL APPROVAL
2020-08-31
LATEST ACTION
2020-08-31
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
MEMANTINE HYDROCHLORIDEPrescription
MEMANTINE HYDROCHLORIDE 2MG/ML · SOLUTION · ORAL
Approval history
2020-08-31UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.